Nov 24 (Reuters) - The U.S. Food and Drug Administration has approved Novartis' gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday. The therapy, branded as Itvisma, was approved for the treatment of spinal muscular atrophy patients of age two years and older who have a confirmed mutation in the survival motor neuron 1 gene....

Nov 25 (Reuters) - * CORPORATE TRAVEL PLATFORM AMEX GBT TAPS ADVISERS TO EXPLORE SALE - BLOOMBERG NEWS Source text: https://tinyurl.com/2artzm5k ...

By Supantha Mukherjee STOCKHOLM, Nov 25 (Reuters) - Estonian ride-hailing company Bolt said on Tuesday it has partnered with Chinese autonomous driving firm Pony.ai as it seeks to add driverless cars to its taxi services in Europe. The companies will first test and validate safety for the fully autonomous, driverless capability before deploying them in various European countries. Bolt's ambition...

Nov 24 (Reuters) - Venezuela's aviation institute told international airlines on Monday that they must resume flights to the country within 48 hours or risk losing their clearance to fly there, the International Air Transport Association (IATA) said. Several international airlines have canceled their flights departing from Venezuela in recent days after the U.S. Federal Aviation Administration warned major airlines...